Navigation Links
UAS Laboratories Presents about Probiotic Selection Criteria, at Scientific Conference
Date:6/26/2012

Eden Prairie, MN (PRWEB) June 26, 2012

Human Microbiome Project Spurs Interest in Probiotics

The recently released findings from the Human Microbiome Project have spurred increased interest in probiotics. A timely International Probiotic Scientific Conference is planned this year in San Antonio, Texas. The conference brings together an international mix of biotech companies, food processing companies and academia. The scientific program will focus on current advances in research, production and use of probiotics with a particular focus on their role in maintaining health and preventing disease.

Dr. S.K. Dash to Present Criteria for Selection of Probiotics

The functional qualities of probiotics relate to the specific strain of micro-organism and the production and handling of the probiotic. Dr. Dash has been a leader in the probiotic field since 1979 and as such has developed experience and knowledge into the properties of individual strains of probiotics as well as the specific requirements of manufacturing and handling probiotic strains. His presentation on Selection Criteria for Probiotics will address strain identity using genetic techniques and in vitro testing to establish probiotic qualities like acid and bile resistance, resistance to digestive enzymes, adherence to human epithelial cells, potential anti-microbial activity, affect on immune cytokines and sensitivity to common antibiotics. Different animal and human testing will be included. Dr. Dash will also describe stabilization techniques to ensure viability of probiotics throughout the supply chain along with Good Manufacturing Practices and considerations for condition-specific probiotic blends. The regulatory environment for probiotics continues to be an important consideration for selection and Dr. Dash will address regulations in the US, European Union and Canada.

About UAS Laboratories, Inc.
UAS Laboratories, Inc. (Eden Prairie, MN USA), established in 1979, is one of the world’s leading biotechnology companies specializing in probiotic discovery, development, research, manufacture and marketing. The company manufactures products containing the trademarked, patented, Lactobacillus acidophilus DDS®-1, a probiotic with over 200 studies. DDS® Probiotics are sold to natural products retailers, health professionals, private label customers and as probiotic raw materials and customer specific blends to manufacturers in the US, and over 48 other countries. UAS Labs was founded by Dr. S.K. Dash, the probiotic pioneer, in 1979. Dr. Dash has previously served as a member of the Board of Directors, Vice President and as a member of the Scientific Advisory Board at the International Probiotic Association and is an Adjunct Professor of Nutrition and Food Science at South Dakota State University. Dr. Dash’s research and innovations in probiotics have earned 2010 Probiotic Award from Frost and Sullivan to UAS Labs and recognition from the Minnesota State Senate.

For more information about UAS Laboratories, Inc please visit http://www.uaslabs.com.

Read the full story at http://www.prweb.com/releases/2012/6/prweb9637338.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Frost & Sullivan Presents 2012 Clinical Diagnostics Company of the Year Award to GenPath Diagnostics of BioReference Laboratories, Inc.
2. Produce Safety Researchers Awarded by ABC Research Laboratories
3. Aviir Laboratories Announce National Agreement with Stratose
4. Aviir Laboratories Announce National Agreement with Three Rivers Provider Network
5. Aviir Laboratories Announce National Agreement With MultiPlan
6. MO BIO Laboratories, Inc. Launches the PowerMicrobiome™ RNA Isolation Kit
7. ARUP Laboratories Announces Creation of Business Innovations Division
8. EMD Millipore Partners with Charles River Laboratories for Improved Viral Clearance Studies
9. John Saltamartine to Lead Operations as VR Laboratories Chief Operating Officer
10. ARUP Laboratories Pathologist, Ronald L. Weiss, MD, Honored With Lifetime Achievement Award for Contributions to Patient Care and Pathology
11. Butamax Early Adopters Group surpasses capacity targets with addition of Big River; Membership represents 11 production facilities and nearly 900 million gallons of ethanol capacity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... , March 24, 2017 On ... trading session at 5,817.69, down 0.07%; the Dow Jones ... and the S&P 500 closed at 2,345.96, marginally dropping ... sectors closed in green, 4 sectors finished in red, ... Friday, Stock-Callers.com has initiated reports coverage on the following ...
(Date:3/23/2017)... ... March 23, 2017 , ... Lajollacooks4u is proud to announce it has become the premiere team-building ... challenges for companies around the world, such as Illumina, HP and Qualcomm, and is ranked ... its increasing popularity is due to its new team building format, a way for teams ...
(Date:3/23/2017)...  GlobeImmune, Inc. today announced it has entered into ... shares of its common stock to NantCell, Inc., a ... the sale of its common stock, NantCell has agreed ... GlobeImmune 200,000 shares, an estimated $2.0 million in value, ... pleased to enter into this strategic agreement with NantCell," ...
(Date:3/23/2017)... YORK , March 23, 2017 ... ... of death, putting significant strain on health care systems, in ... cancer diagnoses rises, so too does the development of innovative ... minimum side effects. Among the many types of cancer treatments, ...
Breaking Biology Technology:
(Date:2/14/2017)... , Feb. 14, 2017  Wake Forest Baptist ... as its new chief executive officer (CEO). Freischlag joins ... John D. McConnell , M.D., who last year ... at the Medical Center, after leading it since 2008. ... full scope of Wake Forest Baptist,s academic health system, ...
(Date:2/10/2017)... , Feb 10, 2017 ... new report "Personalized Medicine - Scientific and Commercial Aspects" ... ... personalized medicine. Diagnosis is integrated with therapy for selection of ... on early detection and prevention of disease in modern medicine. ...
(Date:2/8/2017)... 7, 2017  Aware, Inc. (NASDAQ: AWRE ), ... financial results for its quarter and year ended December 31, ... 2016 was $3.9 million compared to $6.9 million in the ... of 2016 was $0.6 million compared to $2.6 million in ... quarter of 2016 was $0.5 million, or $0.02 per diluted ...
Breaking Biology News(10 mins):